PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z

Désirée E Bennett1, Robert M Mulhall, Mary T Cafferkey

  • 1Epidemiology and Molecular Biology Unit, The Children's University Hospital, Dublin, Ireland.

Insights

New PCR assays identify Neisseria meningitidis serogroups 29E, X, and Z by targeting the ctrA gene. These methods offer specific detection for crucial meningococcal serogroups, aiding in disease surveillance and control efforts.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Epidemiology

Background:

  • Neisseria meningitidis is a significant cause of bacterial meningitis and sepsis.
  • Accurate and rapid identification of meningococcal serogroups is crucial for effective public health interventions and disease control.
  • Existing diagnostic methods may have limitations in differentiating specific serogroups, particularly less common ones.

Purpose of the Study:

  • To develop and validate novel PCR-based assays for the specific identification of Neisseria meningitidis serogroups 29E, X, and Z.
  • To assess the specificity of these newly developed assays against a panel of common and uncommon meningococcal serogroups and nongroupable isolates.

Main Methods:

  • Development of Polymerase Chain Reaction (PCR) primers targeting specific regions of the ctrA gene.
  • Application of PCR assays to identify Neisseria meningitidis serogroups.
  • Testing the specificity of the developed assays using a comprehensive collection of characterized meningococcal serogroups (A, B, C, 29E, H, W135, X, Y, Z) and nongroupable isolates.

Main Results:

  • Successfully designed and implemented PCR-based assays capable of identifying Neisseria meningitidis serogroups 29E, X, and Z.
  • Demonstrated high specificity of the developed assays, with no cross-reactivity observed against other tested meningococcal serogroups or nongroupable strains.
  • The assays accurately detected the target serogroups based on the presence of specific ctrA gene regions.

Conclusions:

  • The developed PCR assays provide a reliable and specific method for identifying Neisseria meningitidis serogroups 29E, X, and Z.
  • These assays can be valuable tools for epidemiological surveillance, outbreak investigations, and clinical diagnostics related to meningococcal disease.
  • Further implementation of these molecular tools can enhance the ability to track and manage Neisseria meningitidis infections globally.